Results 1 to 10 of about 7,270 (143)

Successful live birth via in vitro fertilization in a patient with lymphangioleiomyomatosis: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Lymphangioleiomyomatosis is a rare, estrogen-sensitive multisystem disorder that predominantly affects women of reproductive age. Pregnancy and fertility interventions present a unique challenge in patients with lymphangioleiomyomatosis, as an
Yusen Ou   +7 more
doaj   +2 more sources

Diagnostic Value of Serum VEGF-D in Lymphangioleiomyomatosis: Results of the First Prospective Study in the Russian Federation [PDF]

open access: yesDiagnostics
Background/Objectives: Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease for which serum vascular endothelial growth factor D (VEGF-D) is a recommended diagnostic biomarker. Data from the Russian Federation remain limited. We aimed to evaluate
Marina Makarova   +5 more
doaj   +2 more sources

Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response [PDF]

open access: goldThe Journal of Pathology: Clinical Research, 2020
Lymphangioleiomyomatosis (LAM) is a rare multisystem disease with a variable clinical course. The lungs are infiltrated by nodules of LAM cells, stromal cells and inflammatory cells, causing lung cysts and respiratory failure. We used immunohistochemical
Suzanne Miller   +5 more
doaj   +2 more sources

Uterine lymphangioleiomyomatosis in a premenopausal woman with tuberous sclerosis: A case report [PDF]

open access: yesCase Reports in Women's Health
Lymphangioleiomyomatosis is a rare disease characterized by abnormal smooth muscle cell growth. It primarily occurs in the lungs but can also rarely occur in other organs, in which case it is classified as extrapulmonary lymphangioleiomyomatosis.
Eun Min Lee   +3 more
doaj   +2 more sources

Giant renal angiomyolipoma unmasks underlying lymphangioleiomyomatosis: a case report and literature review [PDF]

open access: yesFrontiers in Medicine
Lymphangioleiomyomatosis (LAM) is an uncommon systemic disease that primarily affects women during their reproductive years and is often linked with renal angiomyolipoma (AML). In this report, we describe a case involving a 30-year-old female patient who
Xuan Zhou   +10 more
doaj   +2 more sources

A Clinical Case of Pulmonary Lymphangioleiomyomatosis

open access: yesТуберкулез и болезни лёгких, 2022
The article describes a clinical case of pulmonary lymphangioleiomyomatosis (LAM) in a 44-year-old female Patient N., who has been suffering from this disease for a long time.
S. S. Kazakova   +2 more
doaj   +1 more source

Effectiveness of pulmonary rehabilitation in lymphangioleiomyomatosis

open access: yesIndian Journal of Respiratory Care, 2021
Lymphangioleiomyomatosis (LAM) is a cystic lung disease frequently associated with reduced exercise capacity, mostly affecting young women. The disease is characterized by progressive pulmonary cystic change, recurrent pneumothorax, chylous pleural ...
Manivel Arumugam   +3 more
doaj   +1 more source

Lymphangioleiomyomatosis and Langerhans cell histiocytosis - two case reports from our practice [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2022
Introduction. Lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis are the most common pulmonary cystic diseases. Although they differ in pathogenesis, they share several features.
Milenković Ana   +4 more
doaj   +1 more source

Microscopic precursor lesions of uterine lymphangioleiomyomatosis associated with incidental nodal lymphangioleiomyomatosis: A case report and discussion of pathogenesis

open access: yesHuman Pathology: Case Reports, 2020
A 47 yo woman underwent resection of an endometrial adenocarcinoma with pelvic lymph node biopsies. She was found to have incidental nodal lymphangioleiomyomatosis (LAM).
Charles M. Lombard
doaj   +1 more source

Tissue‐Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition

open access: yesAdvanced Science, 2023
Lymphangioleiomyomatosis (LAM) is a rare disease involving cystic lung destruction by invasive LAM cells. These cells harbor loss‐of‐function mutations in TSC2, conferring hyperactive mTORC1 signaling. Here, tissue engineering tools are employed to model
Adam Pietrobon   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy